UnitedHealth Group Incorporated (NYSE:UNH) Shares Bought by Cerity Partners LLC

Cerity Partners LLC lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 14.1% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 507,077 shares of the healthcare conglomerate’s stock after acquiring an additional 62,493 shares during the period. UnitedHealth Group accounts for approximately 0.7% of Cerity Partners LLC’s holdings, making the stock its 26th biggest position. Cerity Partners LLC owned approximately 0.06% of UnitedHealth Group worth $296,478,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. China Universal Asset Management Co. Ltd. increased its holdings in shares of UnitedHealth Group by 20.6% in the first quarter. China Universal Asset Management Co. Ltd. now owns 10,867 shares of the healthcare conglomerate’s stock valued at $5,376,000 after buying an additional 1,857 shares in the last quarter. Quent Capital LLC lifted its stake in UnitedHealth Group by 5.5% during the first quarter. Quent Capital LLC now owns 4,196 shares of the healthcare conglomerate’s stock valued at $2,076,000 after buying an additional 217 shares in the last quarter. EntryPoint Capital LLC purchased a new position in shares of UnitedHealth Group in the first quarter worth approximately $75,000. Steel Grove Capital Advisors LLC purchased a new position in UnitedHealth Group during the 1st quarter worth approximately $352,000. Finally, Bamco Inc. NY increased its position in UnitedHealth Group by 14.1% in the 1st quarter. Bamco Inc. NY now owns 57,317 shares of the healthcare conglomerate’s stock worth $28,355,000 after purchasing an additional 7,081 shares during the last quarter. Institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Stock Down 1.1 %

NYSE UNH opened at $590.77 on Friday. The stock has a market capitalization of $543.67 billion, a P/E ratio of 38.49, a price-to-earnings-growth ratio of 1.75 and a beta of 0.58. UnitedHealth Group Incorporated has a 52 week low of $436.38 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.91. The stock has a fifty day moving average of $582.63 and a 200-day moving average of $552.59.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $7.15 EPS for the quarter, beating the consensus estimate of $7.00 by $0.15. The business had revenue of $100.82 billion for the quarter, compared to analysts’ expectations of $99.14 billion. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm’s revenue was up 9.2% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.56 EPS. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 27.6 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be given a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.42%. The ex-dividend date is Monday, December 9th. UnitedHealth Group’s dividend payout ratio is presently 54.72%.

Analyst Upgrades and Downgrades

Several research analysts recently commented on UNH shares. Morgan Stanley dropped their target price on shares of UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating on the stock in a report on Wednesday, October 16th. Truist Financial restated a “buy” rating and set a $625.00 price objective (down previously from $640.00) on shares of UnitedHealth Group in a report on Wednesday, October 16th. Stephens decreased their target price on UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 16th. Barclays decreased their price objective on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating on the stock in a report on Tuesday, October 22nd. Finally, Royal Bank of Canada decreased their price target on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 16th. Four analysts have rated the stock with a hold rating, seventeen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $615.53.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.